CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Deltex numbers suffer as Covid disrupts elective surgery

By David Burrows

12:47, 20 September 2021

Surgeons stand around an operating table
Surgeons at work – Photo: Shutterstock

It has been a tough year for AIM-listed Deltex Medical Group, a specialist in oesophageal Doppler monitoring or measuring the velocity of blood flow.

For the six months to the end of June, the company reported revenues of £1.1m compared to £1.2m in 2020.

Adjusted EBITDA loss was similar at £242,000 (2020: loss of £241,000) with an 8% improvement in loss before taxation of £0.5m (2020: loss of £0.6m).

Severe disruptions continue

In the statement filed to the London Stock Exchange on Monday, the group said: “Trading was challenging in H1 as, pre-Covid-19, 80% of Group revenues were generated from elective surgery which continues to be severely disrupted.”

Commenting on the latest figures, Nigel Keen, chair of Deltex Medical, said: We always expected the first half to be challenging as Covid-19 continues to delay significantly elective surgical procedures around the world; however, we are encouraged by the increases in quarterly probe sales since the beginning of the year.


0.53 Price
+2.920% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.00402


1,948.36 Price
-1.480% 1D Chg, %
Long position overnight fee -0.0185%
Short position overnight fee 0.0103%
Overnight fee time 21:00 (UTC)
Spread 0.30

Oil - Crude

71.98 Price
+2.450% 1D Chg, %
Long position overnight fee -0.0201%
Short position overnight fee -0.0018%
Overnight fee time 21:00 (UTC)
Spread 0.04


27,203.95 Price
+1.140% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 60.00

Keen said he expected activity in the second-half to be stronger than in the first-half due to increased levels of elective surgery around the world and continuing stronger performance by Deltex’s international division.

He added: The significant disruption to the global supply chain of electronic components has been widely reported and is extremely frustrating. It is in marked contrast to the success of the product development work carried out by our engineering team on the new monitor.

The Deltex share price fell over 6% following the latest half-year numbers, down to £1.50 by mid-afternoon trading. 




Read more: Biocon partners with Serum Institute for Covid-19 vaccines

Related topics

Rate this article

Capital Com is an execution-only service provider. The material provided on this website is for information purposes only and should not be understood as an investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page then you do so entirely on your own risk.

Still looking for a broker you can trust?

Join the 535.000+ traders worldwide that chose to trade with

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading